[1]
2025. DRUG DOSAGE REGIMEN FOR GRAFT-VERSUS-HOST DISEASE PROPHYLAXIS IN STEM CELL TRANSPLANTATION: A REVIEW. Journal of Research Administration. 7, 2 (Dec. 2025), 210–222.